IHE

iShares U.S. Pharmaceuticals ETF · PSE

  • Category Health Care
  • Expense Ratio 0.4%
  • Listing Date May 05, 2006
  • Volume 74,526.0
  • Market Cap (AUM) $606.55M

Performance

-4.15%

1W

-2.23%

1M

+3.91%

3M

-2.42%

6M

+5.48%

YTD

+5.08%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Eli Lilly and CompanyLLY26.26%
  • Johnson & JohnsonJNJ21.44%
  • Merck & Co., Inc.MRK4.84%
  • Pfizer Inc.PFE4.72%
  • Zoetis, Inc. Class AZTS4.24%
  • Royalty Pharma Plc Class ARPRX4.14%
  • Catalent IncCTLT4.02%
  • Viatris, Inc.VTRS3.89%
  • Elanco Animal Health, Inc.ELAN3.64%
  • Bristol-Myers Squibb CompanyBMY3.55%

Technical Analysis of IHE 2025-03-14

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 41, Oscillators Score at 45, and a Technical Score of 43, suggesting a lack of strong bullish or bearish momentum. Overall, these scores indicate that the market is currently in a consolidation phase, warranting cautious observation before making any investment ...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.